Net income increased 226.8%
Net income changed +226.8% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income changed +226.8% from the comparable as-filed period.
Operating income changed +31.0% from the comparable as-filed period.
Research & development changed +24.4% from the comparable as-filed period.
Revenue changed +5.2% from the comparable as-filed period.
Gross profit changed +8.2% from the comparable as-filed period.
Cash & equivalents changed -2.6% from the comparable as-filed period.
Debt changed +1.1% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes.
Gross margin changed +42 basis points from the comparable as-filed period.
Inventory changed +0.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating margin changed +54 basis points from the comparable as-filed period.
Selling, general & administrative changed +0.7% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.